The Role of Ectopic Germinal Centers in the Immunopathology of Primary Sjögren's Syndrome: A Systematic Review

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 4, 2013, Pages 368-376

  Risselada, Anna P ^a   Looije, Marjolein F ^a   Kruize, Aike A ^a   Bijlsma, Johannes W J ^a   Van Roon, Joel A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; RHEUMATOID FACTOR; SJOEGREN SYNDROME A ANTIBODY; SJOEGREN SYNDROME B ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTE; LYMPHOMA; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SALIVARY GLAND; SALIVATION; SJOEGREN SYNDROME; SYSTEMATIC REVIEW;

CHORISTOMA; GERMINAL CENTER; HUMANS; SALIVARY GLANDS; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME;

EID: 84873723410     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.07.003     Document Type: Article

References (31)

1. Voulgarelis M., Tzioufas A.G. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol 2010, 6:529-537.
2. Theander E., Vasaitis L., Baecklund E., Nordmark G., Warfvinge G., Liedholm R., et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011, 70:1363-1368.
3. Szyszko E.A., Brokstad K.A., Oijordsbakken G., Jonsson M.V., Jonsson R., Skarstein K. Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther 2011, 13:R2.
4. Reksten T.R., Jonsson M.V., Szyszko E.A., Brun J.G., Jonsson R., Brokstad K.A. Cytokine and autoantibody profiling related to histopathological features in primary sjogren's syndrome. Rheumatology (Oxford) 2009, 48:1102-1106.
5. Le Pottier L., Devauchelle V., Fautrel A., Daridon C., Saraux A., Youinou P., et al. Ectopic germinal centers are rare in sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009, 182:3540-3547.
6. Gatumu M.K., Jonsson M.V., Øijordsbakken G., Skarstein K. Nuclear BCL10 in primary Sjögren's syndrome. J Oral Pathol Med 2009, 38:501-507.
7. Jonsson M.V., Skarstein K. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren's syndrome. J Oral Pathol Med 2008, 37:515-521.
8. Manoussakis M.N., Boiu S., Korkolopoulou P., Kapsogeorgou E.K., Kavantzas N., Ziakas P., et al. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: Correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum 2007, 56:3977-3988.
9. Bombardieri M., Barone F., Humby F., Kelly S., McGurk M., Morgan P., et al. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome. J Immunol 2007, 179:4929-4938.
10. Jonsson M.V., Skarstein K., Jonsson R., Brun J.G. Serological implications of germinal center-like structures in primary Sjögren's syndrome. J Rheumatol 2007, 34:2044-2049.
11. Daridon C., Pers J.O., Devauchelle V., Martins-Carvalho C., Hutin P., Pennec Y.L., et al. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2006, 54:2280-2288.
12. Jonsson M.V., Szodoray P., Jellestad S., Jonsson R., Skarstein K. Association between circulating levels of the novel TNF family members April and BAFF and lymphoid organization in primary sjogren's syndrome. J Clin Immunol 2005, 25:189-201.
13. Jonsson M.V., Salomonsson S., Øijordsbakken G., Skarstein K. Elevated serum levels of soluble E-cadherin in patients with primary Sjögren's syndrome. Scand J Immunol 2005, 62:552-559.
14. Barone F., Bombardieri M., Manzo A., Blades M.C., Morgan P.R., Challacombe S.J., et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum 2005, 52:1773-1784.
15. Szodoray P., Alex P., Jonsson M.V., Knowlton N., Dozmorov I., Nakken B., et al. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol 2005, 117:168-176.
16. Bombardieri M., Barone F., Pittoni V., Alessandri C., Conigliaro P., Blades M.C., et al. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: Relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther 2004, 6:R447-R456.
17. Salomonsson S., Jonsson M.V., Skarstein K., Brokstad K.A., Hjelmström P., Wahren-Herlenius M., et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003, 48:3187-3201.
18. Daniels T.E., Cox D., Shiboski C.H., Schiødt M., Wu A., Lanfranchi H., et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum 2011, 63:2021-2030.
19. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011, 29:621-663.
20. Vinuesa C.G., Sanz I., Cook M.C. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 2009, 9:845-857.
21. Zuckerman N.S., Hazanov H., Barak M., Edelman H., Hess S., Shcolnik H., et al. Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. J Autoimmun 2010, 35:325-335.
22. Bahler D.W., Miklos J.A., Swerdlow S.H. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood 1997, 89:3335-3344.
23. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
24. Hayashi T. Dysfunction of lacrimal and salivary glands in Sjögren's syndrome: Nonimmunologic injury in preinflammatory phase and mouse model. J Biomed Biotechnol 2011, 407031. 2011.
25. Jonsson R., Kroneld U., Bäckman K., Magnusson B., Tarkowski A. Progression of sialadenitis in Sjögren's syndrome. Br J Rheumatol 1993, 32:578-581.
26. van Bijsterveld O.P., Kruize A.A., Bleys R.L. Central nervous system mechanisms in Sjögren's syndrome. Br J Ophthalmol 2003, 87:128-130.
27. ter Borg E.J., Risselada A.P., Kelder J.C. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's syndrome: A retrospective analysis of 65 patients in the Netherlands. Semin Arthritis Rheum 2011, 40:547-551.
28. Seror R., Sordet C., Guillevin L., Hachulla E., Masson C., Ittah M., et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome. Ann Rheum Dis 2007, 66:351-357.
29. Kovács L., Szodoray P., Kiss E. Secondary tumours in Sjögren's syndrome. Autoimmun Rev 2010, 9:203-206.
30. Theander E., Henriksson G., Ljungberg O., Mandl T., Manthorpe R., Jacobsson L.T. Lymphoma and other malignancies in primary Sjögren's syndrome: A cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006, 65:796-803.
31. Cattoretti G., Büttner M., Shaknovich R., Kremmer E., Alobeid B., Niedobitek G. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 2006, 107:3967-3975.